z-logo
Premium
Fenfluramine as add‐on therapy for Dravet syndrome
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1949
Subject(s) - dravet syndrome , medicine , fenfluramine , epilepsy , psychiatry , receptor , serotonin
Fenfluramine (Fintepla) has recently been licensed as add‐on therapy for the treatment of seizures associated with Dravet syndrome. This article summarises its clinical trial efficacy and adverse effects.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here